HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM

NCT00905060 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

BIOLOGICAL: HSPPC-96
DRUG: Temozolomide
PROCEDURE: Standard Surgical Resection

Sponsor

University of California, San Francisco

Collaborators

[object Object]